EBITDA grew 4% and net income rose 13% year-over-year, despite a 6% drop in net sales due to currency effects and lower U.S. volumes. Strong performance in non-Mexican operations and "Better for You" products offset regional challenges.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.